Skip to main content

Articles

Page 7 of 40

  1. Nonalcoholic fatty liver disease (NAFLD) has a multidirectional relationship with metabolic syndrome (MetS) and used to be considered a hepatic manifestation of MetS. Perirenal fat, as a part of visceral adipo...

    Authors: Li Wang, Yuning Pan, Xianwang Ye, Yongmeng Zhu, Yandong Lian, Hui Zhang, Miao Xu, Mengxiao Liu and Xinzhong Ruan
    Citation: Diabetology & Metabolic Syndrome 2023 15:56
  2. Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic ...

    Authors: Ute Linnenkamp, Veronika Gontscharuk, Katherine Ogurtsova, Manuela Brüne, Nadezda Chernyak, Tatjana Kvitkina, Werner Arend, Imke Schmitz-Losem, Johannes Kruse, Norbert Hermanns, Bernd Kulzer, Silvia M. A. A. Evers, Mickaël Hiligsmann, Barbara Hoffmann, Andrea Icks and Silke Andrich
    Citation: Diabetology & Metabolic Syndrome 2023 15:54
  3. Low muscle mass likely results in reduced capacity for glucose disposal, leading to a significant but under-appreciated contribution to increasing the risk of diabetes. But few prospective studies have investi...

    Authors: Yiting Xu, Tingting Hu, Yun Shen, Yufei Wang, Yuqian Bao and Xiaojing Ma
    Citation: Diabetology & Metabolic Syndrome 2023 15:53
  4. Type 1 diabetes mellitus (T1DM) patients are at an increased risk for non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the clinical criteria associated with the diagnosis of Non-Alcoholi...

    Authors: Hanaa Reyad Abdallah, Eman Refaat Youness, Manar Maher Bedeir, Marwa W. Abouelnaga, Wafaa M. Ezzat, Yasser Elhosary, Hazem Mohamed El-Hariri, Mona Abd Elmotaleb A. Hussein, Heba R. Ahmed and Rasha Eladawy
    Citation: Diabetology & Metabolic Syndrome 2023 15:52
  5. Persistence of β cell-function in Type 1 diabetes (T1D) is associated with glycaemia stability and lower prevalence of microvascular complications. We aimed to assess the prevalence of residual C- peptide secr...

    Authors: Monica A. L. Gabbay, Felipe Crispim and Sergio A. Dib
    Citation: Diabetology & Metabolic Syndrome 2023 15:51
  6. Coronary heart disease (CHD) is not only a macrovascular complication of type 2 diabetes mellitus (T2DM). Cardiovascular disease (CVD) is one of the leading causes of mortality among individuals with T2DM. Red...

    Authors: Xiaojuan Jiao, Qin Zhang, Ping Peng and Yunfeng Shen
    Citation: Diabetology & Metabolic Syndrome 2023 15:50
  7. Gestational diabetes mellitus (GDM) is associated with retarded lung development and poor lung health in offspring. Mammalian target of rapamycin (mTOR) is a key regulator of vasculogenesis and angiogenesis. T...

    Authors: Qingqing Luo, Xinqun Chai, Xiaoyan Xin, Weixiang Ouyang and Feitao Deng
    Citation: Diabetology & Metabolic Syndrome 2023 15:49
  8. Serum osteocalcin levels are closely related to metabolic syndrome and cardiovascular disease. This study aimed to investigate the relationship between serum osteocalcin levels and cardiometabolic risk factors...

    Authors: Wei Li, Yan Wang, Jie Dong, Ruiqing Di, Xiaojun Liu and Shengyun Liu
    Citation: Diabetology & Metabolic Syndrome 2023 15:48
  9. The effect of resistance training (RT) in cardiac rehabilitation (CR) on insulin resistance remains elusive. We examined whether the addition of high-load (HL) or low loads (LL) RT has any effect on the levels...

    Authors: Tim Kambic, Mojca Božič Mijovski, Borut Jug, Vedran Hadžić and Mitja Lainscak
    Citation: Diabetology & Metabolic Syndrome 2023 15:47
  10. Sarcopenia is a multifactorial disease characterized by reduced muscle mass and function, leading to disability, death, and other diseases. Recently, the prevalence of sarcopenia increased considerably, posing...

    Authors: Zi-jian Liu and Cui-feng Zhu
    Citation: Diabetology & Metabolic Syndrome 2023 15:46
  11. Experiencing a hyperglycaemic crisis is associated with a short- and long-term increased risk of mortality. We aimed to develop an explainable machine learning model for predicting 3-year mortality and providi...

    Authors: Puguang Xie, Cheng Yang, Gangyi Yang, Youzhao Jiang, Min He, Xiaoyan Jiang, Yan Chen, Liling Deng, Min Wang, David G. Armstrong, Yu Ma and Wuquan Deng
    Citation: Diabetology & Metabolic Syndrome 2023 15:44
  12. Recent studies suggest that angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) [Ang-(1–7)] might have beneficial effects on the cardiovascular system. We investigated the effects of olmesartan on the...

    Authors: Kyuho Kim, Ji Hye Moon, Chang Ho Ahn and Soo Lim
    Citation: Diabetology & Metabolic Syndrome 2023 15:43
  13. Subclinical atherosclerosis is frequently observed in type 1 diabetes (T1D) although the mechanisms and markers involved in the evolution to established cardiovascular disease are not well known. High-density ...

    Authors: Marcos Tadashi K. Toyoshima, Monique F. M. Santana, Amanda R. M. Silva, Gabriela B. Mello, Daniele P. Santos-Bezerra, Marisa F. S. Goes, Adriana A. Bosco, Bruno Caramelli, Graziella E. Ronsein, Maria Lucia Correa-Giannella and Marisa Passarelli
    Citation: Diabetology & Metabolic Syndrome 2023 15:42
  14. Authors: Hanan Khudhair Hussein, Nassrin Malik Aubead, Hamzah H. Kzar, Yasir Salam Karim, Ali H. Amin, Moaed E. Al-Gazally, Tousief Irshad Ahmed, Mohammed Abed Jawad, Ali Thaeer Hammid, Abduladheem Turki Jalil, Yasser Fakri Mustafa, Marwan Mahmood Saleh and Hafez Heydari
    Citation: Diabetology & Metabolic Syndrome 2023 15:41
  15. Estimated pulse wave velocity (ePWV) has revealed excellent performance in predicting cardiovascular disease (CVD) risk. However, whether ePWV predicts all-cause mortality and CVD mortality in populations with...

    Authors: Daidi Li, Feng Cao, Wenke Cheng, Yanyan Xu and Chuang Yang
    Citation: Diabetology & Metabolic Syndrome 2023 15:40
  16. Familial hypercholesterolemia (FH) is an inherited metabolic disorder with a high level of low-density lipoprotein cholesterol and the worse prognosis. The triglyceride-glucose (TyG) index, an emerging tool to...

    Authors: Jun Wen, Qi Pan, Lei-Lei Du, Jing-Jing Song, Yu-Peng Liu, Xiang-Bin Meng, Kuo Zhang, Jun Gao, Chun-Li Shao, Wen-Yao Wang, Hao Zhou and Yi-Da Tang
    Citation: Diabetology & Metabolic Syndrome 2023 15:39
  17. Unhealthy lifestyle has been associated with obesity and type 2 diabetes. Whereas its association with vascular complications in patients with long-duration of type 2 diabetes is still uncertain.

    Authors: Li-Ju Ho, Wayne Huey-Herng Sheu, Su-Huey Lo, Yen-Po Yeh, Chii-Min Hwu, Chien-Ning Huang, Chang-Hsun Hsieh and Feng-Chih Kuo
    Citation: Diabetology & Metabolic Syndrome 2023 15:38
  18. Obesity is associated with gut microbiota disorders, which has been related to developing metabolic syndromes. The research aims to investigate the effects of caffeine treatment on insulin resistance, intestin...

    Authors: Li Chen, Xian-jun Wang, Jie-xin Chen, Jing-cheng Yang, Ling Lin, Xian-Bin Cai and Yong-song Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:37
  19. To evaluate the prevalence of diabetic retinopathy (DR) in Brazilian adults with diabetes mellitus via a systematic review with meta-analysis.

    Authors: Thiago Alves Chagas, Mateus Augusto dos Reis, Gabriel Leivas, Lucas Porto Santos, Agnes Nogueira Gossenheimer, Gustavo Barreto Melo, Fernando Korn Malerbi and Beatriz D. Schaan
    Citation: Diabetology & Metabolic Syndrome 2023 15:34
  20. Diabetic gastroparesis is a severe diabetic complication refers to delayed gastric emptying in the absence of mechanical obstruction of the stomach. Vitamin B12 affects the dynamics of autonomic nervous system...

    Authors: Sally S. Ahmed, Hala A. Abd El-Hafez, Mohamed Mohsen, Azza A. El-Baiomy, Enas T. Elkhamisy and Mervat M. El-Eshmawy
    Citation: Diabetology & Metabolic Syndrome 2023 15:33
  21. Diabetes mellitus is a major risk factor for heart failure. A recent consensus statement recommended annual cardiac biomarker testing (e.g. natriuretic peptide or high-sensitivity cardiac troponin) for all pat...

    Authors: Seung Eun Lee, Juhwan Yoo, Bong-Seong Kim, Han Seok Choi, Kyungdo Han and Kyoung-Ah Kim
    Citation: Diabetology & Metabolic Syndrome 2023 15:32
  22. Bariatric surgery is superior to usual care for diabetes remission. Previous meta-analyses were limited by pooling observational and randomized trials, using various definitions of diabetes remission, and not ...

    Authors: Hyder Mirghani and Ibrahim Altedlawi Albalawi
    Citation: Diabetology & Metabolic Syndrome 2023 15:31
  23. At present, there is no clinical study to elucidate the correlation between vitamin D deficiency and the incidence of diabetic foot osteomyelitis (DFO).This study aims to clarify levels of 25-hydroxyvitamin D ...

    Authors: Ying Tang, Yixuan Huang, Li Luo, Murong Xu, Datong Deng, Zhaohui Fang, Xiaotong Zhao and Mingwei Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:30
  24. Although a recent meta-analysis demonstrated a positive association between serum γ-glutamyltransferase (GGT) and metabolic syndrome (MetS), sex differences in the relationship between GGT levels and MetS risk...

    Authors: Jiwon Kwak, In-Ho Seo and Yong-Jae Lee
    Citation: Diabetology & Metabolic Syndrome 2023 15:29
  25. To determine the prevalence of overweight/obesity and its relationship with metabolic syndrome (MS), fatty liver index (FLI), cardiovascular risk factors (CVRF), and diabetes-related chronic complications (DRC...

    Authors: Marilia Brito Gomes, Deborah Conte Santos, Karla Drummond, André Pinheiro, Luiza Harcar Muniz, Franz Leal and Carlos Antonio Negrato
    Citation: Diabetology & Metabolic Syndrome 2023 15:28
  26. The association between hyperuricemia and metabolic dysfunction-associated fatty liver disease (MAFLD) remains undetermined. This study aimed to examine the association of serum uric acid (SUA) levels with pre...

    Authors: Zhening Liu, Qinqiu Wang, Hangkai Huang, Xinyu Wang and Chengfu Xu
    Citation: Diabetology & Metabolic Syndrome 2023 15:27
  27. This longitudinal study aimed to investigate the effects of nonrestorative sleep on developing metabolic syndrome (MetS) and related diseases in a general Japanese middle-aged population.

    Authors: Yuichiro Otsuka, Yoshitaka Kaneita, Katsutoshi Tanaka, Osamu Itani, Yoshiyuki Kaneko, Masahiro Suzuki, Yuuki Matsumoto and Kenichi Kuriyama
    Citation: Diabetology & Metabolic Syndrome 2023 15:26
  28. Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This ...

    Authors: Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, Naohiro Washizawa, Shuki Usui, Masahiko Miyagi and Takahisa Hirose
    Citation: Diabetology & Metabolic Syndrome 2023 15:25
  29. Diabetes distress is increasingly considered one of the most important psychosocial issues in the care of people with type 1 diabetes (T1D). We analyse whether diabetes distress and depression screening result...

    Authors: Anna Stahl-Pehe, Christina Bächle, Kálmán Bódis, Oana-Patricia Zaharia, Karin Lange, Reinhard W. Holl, Michael Roden and Joachim Rosenbauer
    Citation: Diabetology & Metabolic Syndrome 2023 15:24
  30. Type 2 diabetes mellitus (T2DM) is an expanding global health problem, requiring effective methods for predicting and diagnosing in its early stages of development. Previous studies reported the prognostic val...

    Authors: Xin Wu, Yu Gao, Miyuan Wang, Hongye Peng, Di Zhang, Biyuan Qin, Liang Pan and Guolong Zhu
    Citation: Diabetology & Metabolic Syndrome 2023 15:23
  31. Diabetic kidney disease (DKD) is a serious complication that begins with albuminuria and often leads to a rapid progressive decline in renal function. Niclosamide is a potent inhibitor of the Wnt/β-catenin pat...

    Authors: Basma Mahrous El-fatatry, Sahar Mohamed El-Haggar, Osama Mohamed Ibrahim and Khaled Hamed Shalaby
    Citation: Diabetology & Metabolic Syndrome 2023 15:22
  32. Maturity-Onset Diabetes of the Young (MODY) is an autosomal dominant condition and represents 1–5% of all cases of diabetes mellitus. MODY is often misdiagnosed as type 1 or type 2 diabetes. The rare subtype 5...

    Authors: Sara Amaral, Ana Palha, Paula Bogalho and José Silva-Nunes
    Citation: Diabetology & Metabolic Syndrome 2023 15:21
  33. The optimal glycemic control level in diabetic patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (On-Pump) remains unclear. Therefore, this study aimed to investigate the e...

    Authors: Hongzhao You, Xiaopei Hou, Heng Zhang, Xiaojue Li, Xinxing Feng, Xin Qian, Na Shi, Rong Guo, Xuan Wang, Hansong Sun, Wei Feng, Guangwei Li, Zhe Zheng and Yanyan Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:20
  34. Obesity remains a public health problem worldwide. The high prevalence of this condition in the population raises further concerns, considering that comorbidities are often associated with obesity. Among the c...

    Authors: Lucenda A. Felipe, André L. L. Bachi, Miriã C. Oliveira, Sandra M. B. P. Moreira, João Pedro R. Afonso, Maria E. M. Lino, Vitória Paixão, Carlos H. M. Silva, Rodolfo P. Vieira, Sergio Vencio, Elias I. Jirjos, Carlos A. Malheiros, Giuseppe Insalaco, Wilson R. Freitas Júnior and Luis V. F. Oliveira
    Citation: Diabetology & Metabolic Syndrome 2023 15:19
  35. The prevalence of impaired glucose tolerance and diabetes is much higher in people with cirrhosis than that in the general population. However, there are inadequate concrete guidelines for the management of di...

    Authors: Xiu-Ping Bai, Wen-Jin Du, Hua-Bing Xing, Guo-Hua Yang and Rui Bai
    Citation: Diabetology & Metabolic Syndrome 2023 15:18
  36. Future targets are a promising prospect to overcome the limitation of conventional and current approaches by providing secure and effective treatment without compromising patient compliance. Diabetes mellitus ...

    Authors: Sanchit Dhankhar, Samrat Chauhan, Dinesh Kumar Mehta, Nitika, Kamal Saini, Monika Saini, Rina Das, Sumeet Gupta and Vinod Gautam
    Citation: Diabetology & Metabolic Syndrome 2023 15:17
  37. A maturity-onset diabetes of the young (MODY) calculator has been described and validated for use in European Caucasians. This study evaluated its performance in Brazilians diagnosed with diabetes mellitus (DM...

    Authors: Augusto Cezar Santomauro Jr., Áurea Luiza Fernandes Magalhães, Flávia Tedesco Motta, Lucas Santos de Santana, Pedro Campos Franco, Silvia Maria de Freitas, Jeniffer Johana Duarte Sanchez, Aline Dantas Costa-Riquetto and Milena G. Teles
    Citation: Diabetology & Metabolic Syndrome 2023 15:15
  38. Patients with coronary artery disease (CAD) combined with diabetes have a higher risk of cardiovascular events, and high-sensitivity C-reactive protein (hs-CRP)-to-albumin ratio (CAR) is a novel inflammatory b...

    Authors: Jiawen Li, Pei Zhu, Yulong Li, Kailun Yan, Xiaofang Tang, Jingjing Xu, Weixian Yang, Shubin Qiao, Yuejin Yang, Runlin Gao, Bo Xu, Jinqing Yuan and Xueyan Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:14
  39. To determine the association between triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) for identifying subjects at risk of incident prediabetes and type 2 diabetes mellitus (T2DM).

    Authors: Maryam Tohidi, Samaneh Asgari, Abdolreza Chary, Siavash Safiee, Fereidoun Azizi and Farzad Hadaegh
    Citation: Diabetology & Metabolic Syndrome 2023 15:13
  40. Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) may be involved in pathogenesis of gestational diabetes mellitus (GDM). The aim was to compare GLP-1 and GIP production in fas...

    Authors: Ondrej Krystynik, David Karasek, Michal Kahle, Veronika Kubickova, Dominika Macakova, Lubica Cibickova, Milos Mraz and Martin Haluzik
    Citation: Diabetology & Metabolic Syndrome 2023 15:12
  41. The prevalence of diabetes mellitus has risen considerably and currently affects more than 422 million people worldwide. Cardiovascular diseases including myocardial infarction and heart failure represent the ...

    Authors: Melanie S. Hulshoff, Isabel N. Schellinger, Xingbo Xu, Jolien Fledderus, Sandip K. Rath, Fang Cheng Wong, Sabine Maamari, Josephina Haunschild, Guido Krenning, Uwe Raaz and Elisabeth M. Zeisberg
    Citation: Diabetology & Metabolic Syndrome 2023 15:11
  42. Hyperglycemia in pregnancy (HIP) is suggested to be a risk factor for elevated blood pressure (BP) in offspring. However, the empirical evidence was mixed. Thus, this systematic review and meta-analysis was co...

    Authors: Xinyue Zhang, Yinlin Wang, Wenhan Xiao, Denan Jiang, Jiali Zhou, Xinxin Ye, Shiqi Wu, Shuting Li and Peige Song
    Citation: Diabetology & Metabolic Syndrome 2023 15:10
  43. Metabolic syndrome (Mets) is a common metabolic disorder in which hypoadiponectinemia is one of the consequences for the body caused by inflammation, and vitamin D may help improve inflammatory symptoms. LncRN...

    Authors: Mohammad Rashidmayvan, Reza Sahebi, Amir Avan, Payam Sharifan, Habibollah Esmaily, Asma Afshari, Elyas Nattagh-Eshtivani, Fatemeh Najar Sedghdoust, Malihe Aghasizadeh, Gordon A. Ferns and Majid Ghayour-Mobarhan
    Citation: Diabetology & Metabolic Syndrome 2023 15:9
  44. The effectiveness and limb safety of sodium glucose co-transporter 2 inhibitors (SGLT2i) for patients with type-2 diabetes (T2D) who have received peripheral artery disease (PAD) revascularization are unknown.

    Authors: Hsin-Fu Lee, Chi Chuang, Pei-Ru Li, Yung-Hsin Yeh, Yi-Hsin Chan and Lai-Chu See
    Citation: Diabetology & Metabolic Syndrome 2023 15:8
  45. Declined renal function is associated with physical function impairment and frailty in a graded fashion. This study aimed to examine the relationship between renal function, frailty and physical performance wi...

    Authors: Shuo-Chun Weng, Cheng-Fu Lin, Chiann-Yi Hsu and Shih-Yi Lin
    Citation: Diabetology & Metabolic Syndrome 2023 15:7

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,322,026 downloads
    1,058 Altmetric mentions